CRP and metabolic dysfunction-associated steatohepatitis: NASH prevalence was the highest among subjects with high inflammation (as indicated by CRP level >1 mg/dL) based on all methods except for when Gholam was used individually, NASH appeared to be highest among those with mild inflammation (0.3–1 mg/dL) (p<0.05).